All Cardiometabolic disease articles – Page 2
-
NewsTwo days of oatmeal reduce cholesterol level - thanks to impact on gut microbes
A short-term oat-based diet appears to be surprisingly effective at reducing the cholesterol level. The diet apparently influenced the composition of microorganisms in the gut. The metabolic products, produced by the microbiome, appear to contribute significantly to the positive effects of oats.
-
NewsNexaBiome accelerates development of novel diabetic foot treatment with Scottish Enterprise funding
UK biotechnology company NexaBiome Life Sciences Ltd has received continued funding from Scotland’s national economic development agency, Scottish Enterprise, to accelerate its breakthrough bacteriophage technology for the treatment of diabetic foot infections (DFIs).
-
NewsProbiotics combined with antidiabetic drugs overcome the ‘drug black hole’
A new study addressing the ’microbial drug black hole’ proposes a new microbe–drug synergistic therapeutic strategy and advances the development of precision nutrition-based interventions for type 2 diabetes mellitus.
-
NewsExperts propose fibre as first new essential nutrient in 50 years - as gut microbiome research gathers pace
Nutrition experts are calling for dietary fibre to be officially recognised internationally as an essential nutrient - the first ‘new’ essential nutrient in more than 50 years. They point out that the gut microbiome exists almost exclusively on the dietary fibre we eat.
-
NewsScientists find new way to disarm antibiotic-resistant bacteria and restore healing in chronic wounds
Scientists have discovered a new way that could speed up the healing of chronic wounds infected by antibiotic-resistant bacteria. The study shows how a common bacterium, Enterococcus faecalis (E. faecalis), actively prevents wound healing.
-
NewsResearchers discover how a respiratory bacterium obtains essential lipids from the human body and targets fat-rich tissues
A multidisciplinary team has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae—responsible for atypical pneumonia and other respiratory infections—to obtain cholesterol and other essential lipids directly from the human body.
-
NewsMaternal microbiome compound may hold key to preventing liver disease
Children born to mothers who consume a high-fat, high-sugar diet during pregnancy and breastfeeding face a higher risk of developing fatty liver disease later in life. New research suggests that risk may be reduced by supplementing with a naturally occurring compound produced by healthy gut bacteria.
-
NewsResearchers deploy bacteria to make healthier sugar substitute
Researchers have developed a way to biosynthetically produce an otherwise rare sugar called tagatose, which could very well provide the sweetness and natural taste of table sugar without its potential harms. It might even provide some health benefits.
-
NewsNewly discovered gut microbial molecules in infancy may influence the risk of type 1 diabetes
An international research team has uncovered compelling evidence that gut-microbe-derived molecules may play an important role in shaping the developing immune system during early childhood.
-
NewsThe gut bacteria that put the brakes on weight gain in mice
Research has identified a specific type of gut bacteria, called Turicibacter, that improves metabolic health and reduces weight gain in mice on a high-fat diet. People with obesity tend to have less Turicibacter, suggesting that the microbe may promote healthy weight in humans as well.
-
NewsInside the gut: What our poo could tell us about our diet, gut microbes and health
Researchers have found that molecules in stool samples can accurately reflect what people eat and how their gut microbiome responds, offering a potential new tool to study nutrition and its impact on health.
-
NewsMajor breakthrough against diabetes thanks to a microbial molecule that disarms inflammation
Researchers have uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a microbial metabolite called trimethylamine. TMA, produced by gut bacteria from dietary choline can block a key immune pathway and improve blood sugar control.
-
NewsResearchers identify bacterial enzyme that can cause fatal heart conditions with pneumonia infections
Researchers have identified a bacterial enzyme that may be the reason some people get heart complications with pneumonia, while others do not. Since enzymes create chemical reactions to help bacteria survive, grow, and sometimes attack tissues, zmpB could become a target for future therapies.
-
NewsDo oral bacteria from tooth infections worsen diabetes risk?
A new study demonstrates that Porphyromonas gingivalis and its lipopolysaccharide are potent drivers of both periapical bone destruction and systemic metabolic dysfunction, acting through an IL-17–dependent inflammatory pathway.
-
NewsMetabolites produced in the intestine play a central role in controlling obesity and diabetes
A study has identified a group of metabolites that travel from the intestine to the liver and then to the heart, where they are pumped throughout the body. These metabolites play an important role in controlling metabolic pathways in the liver and insulin sensitivity.
-
NewsGut microbiome connects obesity to cancer, impacting public health
A new review highlights growing scientific evidence that imbalances in gut bacteria can influence metabolism, trigger inflammation, and increase cancer risk. These insights offer new possibilities for disease prevention, early detection, and personalized health care.
-
NewsNew study links gut microbes to common heart disease - suggesting ‘Jekyll and Hyde’ action
Researchers studying gut microbes recently identified 15 bacterial species associated with coronary artery disease. The analysis reveals multiple pathways linked to disease severity, including increased inflammation and metabolic imbalance.
-
NewsNot just a common cold: studies show RSV’s severity and impact on long-term health
Often confused for a common cold, respiratory syncytial virus (RSV) can in fact be serious and should be studied more closely. Researchers found that the illness could be of comparable severity to other more well-known respiratory viral infections (RVIs) – such as influenza and COVID-19.
-
NewsResearch finds higher rare risk of heart complications in children after COVID-19 infection than after vaccination
A whole-population study showed that although these conditions were rare, children and young people were more likely to experience heart, vascular or inflammatory problems after a COVID-19 infection than after having the vaccine — and the risks after infection lasted much longer.
-
NewsSome acute and chronic viral infections may increase the risk of cardiovascular disease
In the weeks following a bout of influenza or COVID, the risk of heart attack or stroke may rise dramatically, and chronic infections such as HIV may increase the long-term risk of serious cardiovascular disease events, according to new, independent research.